Aurobindo Pharma Statistics
Total Valuation
BOM:524804 has a market cap or net worth of INR 1.04 trillion. The enterprise value is 1.02 trillion.
Important Dates
The last earnings date was Wednesday, November 4, 2026.
| Earnings Date | Nov 4, 2026 |
| Ex-Dividend Date | Nov 11, 2026 |
Share Statistics
| Current Share Class | 575.38M |
| Shares Outstanding | n/a |
| Shares Change (YoY) | -0.47% |
| Shares Change (QoQ) | -0.47% |
| Owned by Insiders (%) | 15.36% |
| Owned by Institutions (%) | 32.33% |
| Float | 273.51M |
Valuation Ratios
The trailing PE ratio is 26.01 and the forward PE ratio is 20.29.
| PE Ratio | 26.01 |
| Forward PE | 20.29 |
| PS Ratio | 2.80 |
| PB Ratio | 2.63 |
| P/TBV Ratio | 3.11 |
| P/FCF Ratio | 32.64 |
| P/OCF Ratio | 17.47 |
| PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
The stock's EV/EBITDA ratio is 13.43, with an EV/FCF ratio of 32.21.
| EV / Earnings | 25.60 |
| EV / Sales | 2.77 |
| EV / EBITDA | 13.43 |
| EV / EBIT | 17.87 |
| EV / FCF | 32.21 |
Financial Position
The company has a current ratio of 1.73, with a Debt / Equity ratio of 0.22.
| Current Ratio | 1.73 |
| Quick Ratio | 0.89 |
| Debt / Equity | 0.22 |
| Debt / EBITDA | 1.13 |
| Debt / FCF | 2.72 |
| Interest Coverage | 15.76 |
Financial Efficiency
Return on equity (ROE) is 10.71% and return on invested capital (ROIC) is 10.87%.
| Return on Equity (ROE) | 10.71% |
| Return on Assets (ROA) | 6.98% |
| Return on Invested Capital (ROIC) | 10.87% |
| Return on Capital Employed (ROCE) | 13.60% |
| Weighted Average Cost of Capital (WACC) | n/a |
| Revenue Per Employee | 12.64M |
| Profits Per Employee | 1.37M |
| Employee Count | 29,209 |
| Asset Turnover | 0.65 |
| Inventory Turnover | 1.24 |
Taxes
In the past 12 months, BOM:524804 has paid 18.45 billion in taxes.
| Income Tax | 18.45B |
| Effective Tax Rate | 31.64% |
Stock Price Statistics
The stock price has increased by +45.61% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | +45.61% |
| 50-Day Moving Average | 1,703.63 |
| 200-Day Moving Average | 1,503.68 |
| Relative Strength Index (RSI) | 58.91 |
| Average Volume (20 Days) | 92,610 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, BOM:524804 had revenue of INR 369.13 billion and earned 39.90 billion in profits. Earnings per share was 69.02.
| Revenue | 369.13B |
| Gross Profit | 218.93B |
| Operating Income | 57.24B |
| Pretax Income | 58.32B |
| Net Income | 39.90B |
| EBITDA | 75.35B |
| EBIT | 57.24B |
| Earnings Per Share (EPS) | 69.02 |
Full Income Statement Balance Sheet
The company has 99.78 billion in cash and 86.30 billion in debt, with a net cash position of 13.48 billion.
| Cash & Cash Equivalents | 99.78B |
| Total Debt | 86.30B |
| Net Cash | 13.48B |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 393.98B |
| Book Value Per Share | 684.73 |
| Working Capital | 142.91B |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was 59.24 billion and capital expenditures -27.53 billion, giving a free cash flow of 31.72 billion.
| Operating Cash Flow | 59.24B |
| Capital Expenditures | -27.53B |
| Depreciation & Amortization | 18.11B |
| Net Borrowing | 2.21B |
| Free Cash Flow | 31.72B |
| FCF Per Share | n/a |
Full Cash Flow Statement Margins
Gross margin is 59.31%, with operating and profit margins of 15.51% and 10.81%.
| Gross Margin | 59.31% |
| Operating Margin | 15.51% |
| Pretax Margin | 15.80% |
| Profit Margin | 10.81% |
| EBITDA Margin | 20.41% |
| EBIT Margin | 15.51% |
| FCF Margin | 8.59% |
Dividends & Yields
This stock pays an annual dividend of 7.00, which amounts to a dividend yield of 0.39%.
| Dividend Per Share | 7.00 |
| Dividend Yield | 0.39% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | 1 |
| Payout Ratio | 0.01% |
| FCF Payout Ratio | n/a |
| Buyback Yield | 0.47% |
| Shareholder Yield | 0.86% |
| Earnings Yield | 3.84% |
| FCF Yield | 3.06% |
Dividend Details Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside | |
| Graham Formula Value | |
| Graham Formula Upside | |
Analyst Forecast
The average price target for BOM:524804 is 1,888.59, which is 5.20% higher than the current price. The consensus rating is "Buy".
| Price Target | 1,888.59 |
| Price Target Difference | 5.20% |
| Analyst Consensus | Buy |
| Analyst Count | 27 |
| Revenue Growth Forecast (3Y) | 13.15% |
| EPS Growth Forecast (3Y) | 20.88% |
Stock Splits
The last stock split was on July 20, 2015. It was a forward split with a ratio of 2.
| Last Split Date | Jul 20, 2015 |
| Split Type | Forward |
| Split Ratio | 2 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 6 |